Cite

HARVARD Citation

    Engelstein, R. et al. (n.d.). Immune Monitoring of Patients Treated With a Whole-Cell Melanoma Vaccine Engineered to Express 4-1BBL. Journal of immunotherapy. 39 (8), p. . [Online]. 
  
Back to record